Evoke Wealth LLC Cuts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Evoke Wealth LLC decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 32.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,974 shares of the financial services provider’s stock after selling 1,934 shares during the period. Evoke Wealth LLC’s holdings in iShares Biotechnology ETF were worth $525,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in IBB. BNP Paribas Financial Markets grew its position in shares of iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $55,010,000. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $11,370,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.5 %

Shares of iShares Biotechnology ETF stock opened at $134.09 on Wednesday. The firm has a market cap of $6.11 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The business has a 50-day moving average price of $136.26 and a 200-day moving average price of $139.57.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which will be paid on Friday, March 21st. Investors of record on Tuesday, March 18th will be given a $0.1212 dividend. The ex-dividend date of this dividend is Tuesday, March 18th. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.